Professional notices focus on important regulatory and patient care/safety matters such as new practice standards, changes to pharmacy legislation, drug schedule amendments, etc. They are forwarded to NSPR registrants using the contact information provided by the registrant.
Updated Antimicrobial Stewardship Resources from Nova Scotia Health
Explore the New NSPR Website
Pharmacy Profession Now Under RHPA
New “Patient Records” Policy
June 30th RHPA Transition
Consultation: Patient Records Policy
Launch of New NSCP Pharmacy Technician Assessment
Consultation: RHPA Bylaws
ISMP Analysis of NS Incident Reports
Supplementary Rules for the Sale of Ephedrine and Pseudoephedrine
Physician Assistant and Podiatrist Prescribing
National Drug Schedules: Cetirizine for Use in Children 2 to 11 Years
Health Canada CDSA Webinars Jan 15 & 22
Amendments to Prescribing Standards: Uncomplicated Cystitis
Removal of Age Limit for Drug Administration by Injection
New Standards Regarding Sexual Misconduct
Consultation: RHPA Bylaws
Educational Video on New Opioid Use Disorder Standards
Launch of NSCP Practice Feedback Program
Important: New Platform for NSCP Licence and Permit Renewals Opens
NS Community Pharmacy Error Reporting & New ISMP Educational Opportunity
Mainpro+ Programs Approved for Meeting CE Requirements
Clarification on Referral to Abortion Services
Updated Practice Policy: Return of Medication
New Standards for the Treatment of Opioid Use Disorder
Update: Requirements for Sale of Single Ingredient Ephedrine and Pseudoephedrine
Addition to Prescribing Standards: HIV PrEP
Clarification: Physician Assistant Prescribing
Updated Practice Policies – Reference Requirements; Management of CDSA/Z-Drugs
Updated Refrigeration Policy & FAQs
Amendments to Prescribing Standards: Early Lyme Disease & GAS Pharyngitis
Learnings from NS Error Reporting
Update: Removal of Ephedrine and Pseudoephedrine from Drug Schedules
Using Patient Lab Values to Prevent Harm
Launch of Public Quality Survey
Prescribing Antimicrobial Prophylaxis Initiated by Public Health
Amendment to Prescribing Standards – RSV Vaccine
Are pharmacists authorized to prescribe Arexvy?
NSCP YouTube Compounding Videos
National Incident Data Repository Safety Brief
Clarified Standard: Prescribing for Lyme Prophylaxis
Rescinded – Signature Criteria for a Valid Prescription
Pharmacy Workforce Challenges
Amendments to the Centralized Prescription Processing Standards
Prescriptions Written by Physician Assistants
Pharmacy Closures and Evacuations Due to Wildfires
Amendments to Prescribing Standards: CDSA, Conjunctivitis & Contraception Management
SDM IT Disruption: Update from DIS
SDM IT Disruption: Implications for NS DIS Profiles
Urgent Notice of Scam Involving Narcotics
Omicron Infection Prevention and Control Measures
Vaccine Clinic Errors: Contributing Factors and Lessons Learned
Incorporation of COVID-19 Provisions into Standards
Addressing Medication Shortages During Surge in Respiratory Illnesses
Amendment to Prescribing Standards
Witnessed Opioid Agonist Therapy Ingestion during the Holidays
Mitigating Risks When Administering Multiple Vaccines
Shortage of Children’s Acetaminophen and Ibuprofen: Information and Resources
Updated NSCN/NSCP Joint Statement on Nurses Employed in Community Pharmacies
Caution when Administering Look-Alike COVID-19 Vaccines
Patient Access to Medications During IT Disruption
Sale of Homeopathic Products in Community Pharmacies
Processing Pharmacist-Prescribed Prescriptions
Hurricane Fiona: Temporary Pharmacy Closures
Public Health Guidance on Continued COVID-19 Masking
Children’s Acetaminophen and Ibuprofen Shortage
Access and Use of Lab Values through SHARE
Administration of COVID and Flu Vaccines for Children Under 2 Years of Age
Hospital Dispensed Medications in NS DIS
Prescribing OAT to Bridge Patients Released from Correctional Facilities
Pharmacist Prescribing Inhaled Budesonide for Mild SARS-CoV-2 Respiratory Symptoms
Change in Health Canada Submission of Loss or Theft Reports
Reduced Age Limit for Drug Administration of Flu and COVID Vaccines
Paxlovid™ (nirmatrelvir/ritonavir) Information and Resources
NSH COVID-19 Antiviral Therapy Consult Service; Inhaled Budesonide
Reminder: Tramadol Rescheduling
Paxlovid™ (nirmatrelvir/ritonavir) Oral Treatment for COVID-19
Updated Health Canada s.56 Exemption: Transfer from Other Provinces
Guidance: Asymptomatic COVID-19 Testing in Community Pharmacies
Position Statement: Meeting Patient Needs; Harm Reduction Policy
Pharmacist Prescribing Chemoprophylaxis for Lyme Disease
Extension of Health Canada CDSA Exemption
Preparation of COVID-19 Vaccine Syringes
Temporary Pharmacy Closures; COVID-19 Vaccine Screening
Critical Use of PPE During Third Wave
Update: Pharmacy Involvement in the COVID-19 Vaccine Rollout
Changes to MAiD Legislation
Registrar’s Advisory on COVID-19 Immunization; Nurses as Immunizers in Pharmacies
Confirmation on Requirement for Duplicate Prescription Forms
Update: Pharmacy Involvement in the COVID-19 Vaccine Rollout
Standards of Practice: Non-Sterile Compounding
Pharmacy Involvement in the COVID-19 Vaccine Rollout
Moderna COVID-19 Vaccine Webinar – Dec 30
Upcoming Moderna Webinar – Dec 29
Guidance: Pharmacists as Prescribers
Practice Settings Approved by Council: NSH and IWK
Amendments to Pharmacy Practice Regulations and Standards of Practice
NS Drug Information System (NS DIS) Prescription Transfers for Monitored CDSA Drugs
Update on Pharmacy Practice Provisions for COVID-19
Mandatory Use of Non-Medical Masks in Community Pharmacies
Newly Licensed Pharmacists
NSCP Response to Racial Injustice
Change to 30 Days Supply Measure
Clinical Practice Consultant Service
Opioid Agonist Therapy (OAT) Community of Practice Resource and Physician Call List
Amendments to Drug Administration Standards
Temporary Suspension of 180 Days Renewal Limit; Keeping DIS Current
Pharmacy Infection Control Measures During COVID-19
Messages from Public Health
COVID-19 Practice Questions and Pharmacy Closures
CCP Discontinuation; Prescribing During the COVID-19 Pandemic; COVID-19 Screening
Update: Urgent Message Re: Antiretroviral Rxs
COVID-19 Pharmacy Practice Provisions and Guidance
Emergency Protocol for Prescribing CDSA Drugs; Changes to NSPMP and DIS; Fax Transmission Policy
Health Canada CDSA Exemption; Verifying Authenticity; Provision of OAMT
Dispensed Days Supply; Prescribing in a Public Health Emergency/Crisis
COVID-19 Guidance from NSCP
Discontinuation of Continued Care Prescription (CCP) Agreements
Sale of Homeopathic Products
Adoption of Prescribing into Routine Pharmacy Practice
Practice Setting Approved by Council
Witnessed Methadone or Buprenorphine/Naloxone Ingestion during the Holidays
Pharmacists Play a Critical Role in Promoting Vaccine Acceptance
Changes to Standards of Practice
New Prescribing Authority
Clarified Reporting Requirements in Standards of Practice: Continuous Quality Assurance
Mandatory Reporting of Vaccine Administration by Pharmacists into the NS DIS Immunization Module
Pending Discontinuation of Continued Care Prescription Agreements (CCPs)
Update: Clarification of the Signature Requirements for a Valid Prescription
PPMS System Integrations with NS DIS Immunization Module
Archived Webinar – Standards of Practice: Prescribing Drugs
Changes to Requirements for Witnessing Buprenorphine/Naloxone Dosing
Revised Prescribing Standards
